healthcare-thumbnail.png

Cancer Anorexia market Research Report

Published: 2025 - January

Report Code: VMR-17731

Region: Global

Request Sample
Customization
Ask an Expert
Enquire Enquire Before Buying

Cancer Anorexia Market Analysis

The Cancer Anorexia market focuses on managing a critical and often debilitating condition in cancer patients, characterized by the loss of appetite and significant weight loss. Cancer anorexia occurs due to a combination of metabolic, inflammatory, and neuroendocrine changes triggered by both the cancer itself and its treatment. This syndrome significantly impacts a patient's quality of life, further complicating the management of cancer, and often correlates with a worse prognosis. As a result, effective therapeutic strategies aimed at reversing anorexia and improving nutritional intake are crucial in supporting cancer patients' overall well-being.

Disruptive Impact and Opportunities:

The market is evolving with innovative therapies that address the underlying mechanisms of cancer anorexia, leading to more personalized and effective treatments. Emerging drugs targeting specific pathways are creating new opportunities for improving patient outcomes. These novel treatments offer significant potential for better symptom management, reducing the impact of cancer treatment, and improving survival rates. As the market matures, there is growing demand for targeted interventions that are easier to administer, safer, and provide more durable benefits.

Cancer Anorexia Market Segmentation: Emerging Drugs

  • Adlumiz/Edolmizu

  • ART27.13

  • NGM120

Cancer Anorexia Market Segmentation: Marketed Drugs

  • Progestagens

  • Dexamethasone

  • Corticosteroids

Key Companies:

  • Helsinn Healthcare

  • Artelo Biosciences

  • NGM Biopharmaceuticals

  • Merck & Co. Inc.

  • Aphios Corporation

  • Bristol-Myers Squibb Company

  • Pfizer

Cancer Anorexia Market Segmentation: By Type

  • Primary Cancer Anorexia

    • Non-metastatic Cancer Anorexia

    • Metastatic Cancer Anorexia

  • Secondary Cancer Anorexia

    • Cancer Treatment-Induced Anorexia (e.g., due to chemotherapy or radiotherapy)

Cancer Anorexia Market Segmentation: By Administration Type

  • Oral Administration

  • Intravenous (IV) Administration

  • Subcutaneous Administration

  • Transdermal Administration

  • Others (e.g., Intramuscular)

What’s in It for You?

  • Key insights into the emerging drugs poised to disrupt cancer anorexia treatment paradigms.

  • Analysis of the competitive landscape and market dynamics, highlighting opportunities for growth.

  • Evaluation of unmet needs in the cancer anorexia space, guiding investment and development strategies.

  • A comprehensive understanding of the strategic direction and partnerships required for market leadership.

  • Recommendations on navigating regulatory pathways and optimizing market access for novel treatments.

  1. Cancer Anorexia Market - Executive Summary

    1. Introduction

    2. Objectives

    3. Key Findings

      1. Market Size 2025 & 2030: By Key Country (10MM)

      2. Global Market Size 2025 & 2030: By Key Segment

      3. Key Investments & Startup Analysis

    4. Research Methodology

  2. Understanding the Disease

    1. Disease Overview

    2. Classification

    3. Signs and Symptoms

    4. Risk Factors

    5. Causes

    6. Disease Biology & Digital Innovations

    7. Stages & Staging System

    8. Diagnostic Algorithm

    9. Current Treatment Practices & Algorithm

    10. Current Standard of Care and Treatment Gaps

    11. Patient Demographics and Treatment Pathways

  3. Guidelines

  4. Unmet Needs

  5. Epidemiology and Patient Population

    1. Epidemiology Key Findings

    2. Assumptions and Rationale: 10MM

    3. Epidemiology Scenario: 10MM

    4. U.S. Epidemiology Scenario

    5. EU-5 Epidemiology

      1. U.K. Epidemiology Scenario

      2. Germany Epidemiology Scenario

      3. France Epidemiology Scenario

      4. Italy Epidemiology Scenario

      5. Spain Epidemiology Scenario

    6. Japan Epidemiology Scenario

    7. China Epidemiology Scenario

    8. Australia Epidemiology Scenario

    9. India Epidemiology Scenario   

  6. Real-world Data & Real-world Evidence

  7. Drug Development Landscape

    1. Existing Key Drug Candidate Profiles/ Marketed Therapies

    2. Competitive Analysis and Differentiation

    3. Overview of Similar/Competing Drugs in Clinical Trials

    4. Future Trends and Emerging Drugs

  8. Regulatory Strategy and Potential Challenges

    1. Regulatory Pathways in Key Markets

    2. Anticipated Regulatory Hurdles and Mitigation Strategies

    3. Case Studies in Oncology Drug Regulation

    4. Impact of Potential Changes to Regulatory Framework

  9. Commercial Landscape

    1. Market Size & Growth Rates

    2. Key Approvals & Anticipated Loss of Exclusivity

    3. PESTLE & Porter’s Five Forces Analysis

    4. Market Shares, Positioning/Ranking

    5. Market Drivers

    6. Identification of Threats

    7. Digital Evolution in Commercialization

  10. Market Segmentation

  11. Pricing, Reimbursement, and Access

    1. Competitive Pricing Analysis

    2. Reimbursement Landscape and Challenges

    3. Strategies for Market Access and Equity

    4. Patient Spending/Expenditure Analysis

  12. Future Trends, Disruptions, and Opportunities

    1. Analysis of Emerging Trends

    2. Technological Impact

    3. Impact of Potential Market Disruptors

    4. Opportunities for Future Development and Expansion

    5. Considerations for Investment Opportunities

  13. Global Market Dynamics

    1. Regional Regulatory Disparities

    2. Cross-Border Partnership Strategies

    3. Global Supply Chain Dynamics

    4. Case Studies: Success and Failure in Global Markets

    5. Strategies for Global Expansion and Localization

  14. Company Profiles

 

 

Download Sample

↻

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Request Sample
Customization
Ask an Expert
Enquire Before Buying
customer-support

Analyst Support

Every order comes with Analyst Support.

report-custom

Customization

We offer customization to cater your needs to fullest.

verify

Verified Analysis

We value integrity, quality and authenticity the most.

© 2025 Virtue Market Research. All Rights Reserved.